This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With oncology drug sales set to top $390 billion by 2027 , lifescience companies are aligning efforts to prioritize this critical market opportunity ahead of competitors. When key healthcare stakeholders – caregivers, patients, scientists, physicians, and policymakers – share ideas, everyone’s healthcareimproves,” Lance says.
What You Should Know: – Carta Healthcare , which ignites healthcareimprovement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.
The latest AI innovations from Microsoft Cloud for Healthcare , with our partners, empower patients, providers, payors, and lifesciences organizations: Patients can access personalized care. Payors gain insights to improve operational efficiency and enhance patient outcomes.
Kayt Leonard, Global Health Care and LifeSciences Strategic Advisor at SAS We hear it every day, right? Articles and headlines touting “the healthcare industry is constantly evolving and changing” to be more consumer-focused and patient-centric. But is that really all that true? questionable. questionable. And that progress?
Josh Schoeller, CEO of LexisNexis Risk Solutions Health Care, recently shared industry insights in a candid interview with HIStalk, a healthcare technology industry blog. Leading this business since 2018, Schoeller is responsible for delivering solutions across health plan, hospital and health system, pharmacy, and lifescience markets.
Chris Althoff, former senior consulting partner and Head of Marketing, emtelligent developer of AI-powered deep learning that structures medical text and unlocks hidden insights AI will fundamentally reshape healthcare across providers, payers, and lifesciences in the coming year.
Care 24/7 extends and personalizes our client’s Microsoft Cloud for Healthcare footprint to deliver better patient and clinician experiences, data driven insights, and provides a scalable and secure platform from which to continue to innovate and evolve in this digital age.”
Focusing in on The Quintuple Aim – care team well-being Weaving together the WHO ethical principles with team-based care leads me to think about The Quintuple Aim, the five elements that the Institute for HealthcareImprovement identified for our True North for making health care better.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content